Dr. Todd H. Doyle, MD

Dr. Doyle practices at Columbia Memorial Health in Hudson, New York, part of Albany Med Health System.

Dr. Doyle's NPI, 1861493660, was assigned on August 3, 2005. Dr. Doyle graduated from Albany Medical College in 1996. Dr. Doyle holds New York license 220565.

Dr. Doyle's primary practice is Columbia Memorial Health, at 71 Prospect Avenue, Hudson, NY 12534 in Columbia County. The practice phone is (518) 828-7601.

Dr. Doyle's primary practice is Columbia Memorial Health in Hudson, New York, part of Albany Med Health System. The medical group on file is New York Oncology Hematology. Dmand AI also links Dr. Doyle to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Doyle practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Doyle's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Doyle is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Doyle's licenses on file in 2 states: New York and Pennsylvania.

Dmand AI lists anal cancer radiation, bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation and lung cancer radiation among the conditions Dr. Doyle treats.

CMS data shows 1,094 Medicare services from Dr. Doyle across 19 procedure codes in 2024, for 161 Medicare patients. Medicare paid $262,339 for them. Every service was in an office.

CMS counts 161 Medicare patients who saw Dr. Doyle in 2024. The largest group is 65 to 74, with 73 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Doyle's median patient age at 71, with 46% women.

In 2024, Dr. Doyle wrote 56 Medicare Part D claims for 32 patients. 100% of them were for generic drugs. CMS names the drug for 44 of them, across 3 drugs with 11 or more claims each, at $843 in total drug cost. In 2022, CMS named 74 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Doyle for performance year 2024, reported as part of a group. Dr. Doyle accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Doyle to 1 clinical trial. Conditions studied include Lung Neoplasms and Thoracic Neoplasms.

CMS Open Payments shows 5 general payments to Dr. Doyle from 4 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $160.

Dmand AI lists 1 award for Dr. Doyle, most recently CMS Stage 1 2012 in 2012.

Dr. Doyle graduated from Albany Medical College in 1996.

Dr. Doyle is in network with 19 carriers, including Aetna, MVP Health Care and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.